Approval · Notice of Compliance 3145 · 1998
TOMUDEX: Notice of Compliance 3145
Issued August 6, 1998
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3145
- Date
- August 6, 1998
- Company
- Zeneca Pharma Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Provides for: product monograph revision and modification to dosing schedule for renal impaired patients
- Therapeutic class
- Antineoplastic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TOMUDEX | Not yet assigned | — |
Medicinal ingredients
- RALTITREXED 2 MG per VIAL